AzTrials
AzTrials

Eye ChangeNCT06436820

ICP & Outflow Study

An observational study of Eye Change and Idiopathic Intracranial Hypertension, run by Guy's and St Thomas' NHS Foundation Trust.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)). Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Lumbar puncture
Type of treatment
Surgery or procedure
How many people
66 participants
Where
No sites listed yet
Study dates
Jun 2024to Nov 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Adult, Older adult

Study population: Patients will be recruited from neuro-ophthalmology clinics and neurology clinics in St Thomas hospital London UK

Who may be able to join

  • Males or female between the ages of 18 and 80 (inclusive).
  • Able to understand the study and give informed consent.
  • Willing, able and available to participate in all aspects of the study.
  • Able to undergo accurate tonography.
  • Diagnosis of Idiopathic intracranial hypertension (IIH) or suspected diagnosis of IIH as determined by a consultant subspecialist neurologist or neuro-ophthalmologist.
  • Control group will only include:
Show all 9Show fewer
  • Individuals requiring lumbar puncture as part of their standard care for reasons other than suspected raised intracranial pressure e.g. for cerebrospinal fluid (CSF) sampling to analyse oligoclonal bands or other conditions necessitating lumbar puncture for diagnostic/prognostic purposes.
  • Individuals suspected of having a raised intracranial pressure but, upon measurement of the opening pressure, are found to have an intracranial pressure within normal limits.*
  • In this study, where there are considered to be signs of raised intracranial pressure as judged by a consultant neuro ophthalmologist or neurologist, in combination with an opening CSF pressure 20cmH2O or greater, this will be taken as a raised intracranial pressure. Normal CSF pressure is taken as 19cmH2O or lower. In asymptomatic patients, pressures of up to 25cmH2O will be considered normal.

Who cannot join

  • Under 18 or over 80 years of age.
  • Diagnosis of ocular hypertension (ocular hypertension is defined as any individual with an intraocular pressure above 24mmHg measured on Goldman tonometry, irrespective of corneal thickness. This applies to intraocular pressure measured historically as well on the day of assessment).
  • Diagnosis of glaucoma of any subtype (glaucoma is defined on the basis of any glaucomatous optic nerve head appearance [including that defined on the basis of optic nerve head optical coherence tomography] or visual field defect, irrespective of intraocular pressure).
  • Diagnosis of any significant retinal, corneal or other ocular abnormality aside from optic nerve head oedema secondary to raised ICP.
  • Previous intraocular surgery or any surgery in which the conjunctiva has been breached e.g. optic nerve sheath fenestration or squint surgery.
  • Diagnosis of raised intracranial pressure secondary to space occupying lesions.
Show all 10Show fewer
  • Any central nervous system or other systematic disorder that is likely to make lumbar puncture high risk or likely to render accurate recording of opening pressures unreliable.
  • Mental impairment conflicting with informed consent.
  • Patients who might not adequately understand written information given in English or verbal explanations in English will not be included as participants in the study must be able to understand English to complete some of the tests.
  • Participants will not be included if they are involved in research deemed by the investigators to impact the outcomes of this study.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: The Relationship Between Intracranial Pressure and Aqueous Outflow in Idiopathic Intracranial Hypertension

This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)).

Through observing changes in aqueous outflow facility in patients scheduled for lumbar Puncture (LP) as part of their routine care the objectives we aim to answer include:

Read more
  • Investigating the effect of lumbar puncture induced reduction in ICP on patients with known or suspected IIH, compared to control patients, who will be receiving LP for reasons not pertaining to high pressure.
  • Comparing pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients.

Outside of the standard care provided for these patients as part of their scheduled lumbar puncture, they will have measurements of their eye taken before and after their lumbar puncture.

Read the detailed description

This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)).

The effect of lowering intracranial pressure on aqueous outflow will be examined by taking additional measurements before and after a procedure called a lumbar puncture (LP). These measurements include a scan to measure the dimensions of the eye, intraocular pressure reading, and a non-invasive technique to measure aqueous outflow (electronic Schiotz tonography) which is used regularly in the eye research unit at St Thomas' Hospital.

Study participants will already be scheduled for a lumbar puncture as they have known or suspected IIH, and LP is routinely used to investigate this. Additionally, control participants having LP for reasons not pertaining to a condition that may elevate intracranial pressure will also be included. Study participants will finish their involvement following the second aqueous outflow reading, after their LP.

A lumbar puncture procedure directly measures the intracranial pressure, but also reduces the pressure in the process. If aqueous outflow is measured before and after lumbar puncture, it will provide more information about whether the change in intracranial pressure affects the intraocular pressure due to a change in the rate of fluid flowing out of the eye. If a relationship between intracranial pressure and aqueous outflow is found to be present, it may offer an alternative non-invasive measurement for intracranial pressure. Additionally, this study would highlight an avenue of investigation into dysregulation of intraocular pressure in conditions such as glaucoma. Similarly, negative findings would help inform ongoing discussions and controversies in the literature regarding relationships between intraocular pressure and intracranial pressure.

Being tested
Lumbar puncture
Medical subject headings
Pseudotumor Cerebri

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lumbar punctureProcedure or surgery

    Lumbar puncture procedure performed within a clinical setting

Study groups in NCT06436820
Study groupRoleWhat they receive
Suspected IIH patient groupPatients with suspected Idiopathic intracranial hypertension, who require a lumbar puncture as part of their standard care.
Receives: Procedure: Lumbar puncture
Control groupPatients who require lumbar puncture for reasons not pertaining to raised intracranial pressure as part of their standard care.
Receives: Procedure: Lumbar puncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure the effect of LP induced change in intracranial pressure on outflow facility in patients with idiopathic intracranial hypertension compared to control patients

    To investigate the effect of lumbar puncture induced changes in intracranial pressure on aqueous outflow facility in patients with known or suspected idiopathic intracranial hypertension, compared to control patients.

    Measured: 18 Months

Secondary outcomes (1)
  1. Measure the difference in outflow facility between patients with idiopathic intracranial hypertension and control patients prior to lumbar puncture

    To compare pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients.

    Measured: 18 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2024
  2. Study startJun 2024 (estimated)
  3. Primary completionNov 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06436820
Sponsor's protocol ID
310393.
Status last verified
May 2024
First submitted
24 May 2024
Last updated
12 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Eye Change and Idiopathic Intracranial Hypertension, run by Guy's and St Thomas' NHS Foundation Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kin Sheng Lim (02071884885, sheng.lim@gstt.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure the effect of LP induced change in intracranial pressure on outflow facility in patients with idiopathic intracranial hypertension compared to control patients (time frame: 18 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in